(SUSM) iShares MSCI EM SRI USD - Ratings and Ratios
Emerging Markets, Equity, Tracking, Index, Fund
Description: SUSM iShares MSCI EM SRI USD
The iShares MSCI EM SRI UCITS ETF USD (Acc) CHF is an exchange-traded fund that tracks the Morningstar Emerging Markets TME NR USD Index, providing investors with exposure to a diversified portfolio of emerging markets equities that meet certain sustainability and responsible investment criteria.
This ETF is listed in Switzerland and is categorized under Global Emerging Markets Equity. As a UCITS-compliant fund, it adheres to the Undertakings for the Collective Investment in Transferable Securities directive, making it accessible to a broad range of investors across Europe.
From a technical analysis perspective, the ETFs price is currently at 8.26, indicating a bullish trend as it is above its 20-day, 50-day, and 200-day simple moving averages (SMA20: 7.95, SMA50: 7.53, SMA200: 7.52). The Average True Range (ATR) stands at 0.10, or 1.18%, suggesting relatively low volatility. Given the ETFs position above its SMAs and near its 52-week high of 8.26, it may continue to experience upward momentum, potentially driven by investor appetite for emerging markets exposure with a focus on sustainable and responsible investments.
With Assets Under Management (AUM) totaling 2775.47M USD, the fund demonstrates significant investor confidence and scale, which can contribute to its liquidity and operational efficiency. The substantial AUM also indicates that the fund is well-established and has attracted considerable interest from investors seeking emerging markets exposure with an SRI (Sustainable and Responsible Investment) focus.
Forecasting the ETFs future performance involves analyzing both technical and fundamental data. Given the current bullish trend and the funds strong AUM, theres potential for the ETF to continue its upward trajectory. If the emerging markets continue to attract investment due to their growth potential and the ETFs focus on SRI aligns with increasing investor demand for sustainable investments, the price could potentially reach new highs. A break above the current 52-week high could signal further growth, potentially targeting the next resistance level. Conversely, a decline below the SMA50 could indicate a reversal in the bullish trend.
Additional Sources for SUSM ETF
SUSM ETF Overview
Market Cap in USD | 2,775m |
Category | Global Emerging Markets Equity |
TER | 0.25% |
IPO / Inception | 2016-07-11 |
SUSM ETF Ratings
Growth Rating | 7.90 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | 1.42 |
Analysts | - |
Fair Price Momentum | 8.12 USD |
Fair Price DCF | - |
SUSM Dividends
Currently no dividends paidSUSM Growth Ratios
Growth Correlation 3m | 97.1% |
Growth Correlation 12m | 38.3% |
Growth Correlation 5y | -32% |
CAGR 5y | 5.61% |
CAGR/Max DD 5y | 0.15 |
Sharpe Ratio 12m | 0.79 |
Alpha | 6.24 |
Beta | 0.654 |
Volatility | 15.19% |
Current Volume | 3k |
Average Volume 20d | 10.7k |
Stop Loss | 8.2 (-3.1%) |
As of July 16, 2025, the stock is trading at USD 8.46 with a total of 2,950 shares traded.
Over the past week, the price has changed by -0.21%, over one month by +2.04%, over three months by +18.68% and over the past year by +14.98%.
Neither. Based on ValueRay´s Analyses, iShares MSCI EM SRI USD is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 7.90 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SUSM is around 8.12 USD . This means that SUSM is currently overvalued and has a potential downside of -4.02%.
iShares MSCI EM SRI USD has no consensus analysts rating.
According to our own proprietary Forecast Model, SUSM iShares MSCI EM SRI USD will be worth about 9.2 in July 2026. The stock is currently trading at 8.46. This means that the stock has a potential upside of +8.16%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 9.2 | 8.2% |